FDA approves Simtriyo for treating ADHD in children and adults

2 months ago 9
The U.S. Food and Drug Administration has approved Simtriyo (centanafadine) for the attraction of attention-deficit/hyperactivity upset (ADHD) successful adults and children 6 years and older weighing ≥20 kg.
Read Entire Article